CDC Grand Rounds: Chlamydia Prevention: Challenges and Strategies for Reducing Disease Burden and Sequelae

Satterwhite, C. L.; Gottlieb, S. L.; Romaguera, R.; Bolan, G.; Burstein, G.; Schuler, C.; Popovic, T.
April 2011
MMWR: Morbidity & Mortality Weekly Report;4/1/2011, Vol. 60 Issue 12, p370
The article reveals the issues and plans for cutting the spread of chlamydia, a sexually-transmitted disease initiated by bacterium Chlamydia trachonatis. In 2009, 1,244,180 cases were notified all over the U.S., although about 2.8 million people are infected annually. The disease is managed through nucleic acid amplification exams as means of diagnosis, wherein the disease comes from women who have reproductive problems, and treated with either 1 dose of oral azithromycin or a 1-week doxycycline treatment.


Related Articles

  • Chlamydia trachomatis variant not detected by plasmid based nucleic acid amplification tests: molecular characterisation and failure of single dose azithromycin. Magbanua, Jose Paolo V.; Beng Tin Goh; Michel, Claude-Edouard; Aguirre-Andreasen, Aura; Alexander, Sarah; Ushiro-Lumb, Ines; Ison, Catherine; Lee, Helen; Goh, Beng Tin // Sexually Transmitted Infections;Jul2007, Vol. 83 Issue 4, p339 

    Objective: To characterise a Chlamydia trachomatis variant strain from a patient with non-gonococcal urethritis (NGU) whose first void urine (FVU) displayed discrepant Ctrachomatis test results and describe the clinical response to treatment.Methods: The FVU specimen...

  • Adolescence and the other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia. Williams, H.; Tabrizi, S.N.; Lee, W.; Kovacs, G.T.; Garland, S. // Sexually Transmitted Infections;Feb2003, Vol. 79 Issue 1, p31 

    Discusses the prevalence of and risk factors for Chlamydia trachomatis infection to determine the role of universal versus targeted testing. High prevalence of C. trachomatis indicating that universal testing should be undertaken in the inner city clinic; Young age may not be a risk factor for...

  • Opportunistic screening for genital chlamydial infection. II: Prevalence among healthcare attenders, outcome, and evaluation of positive cases. Pimenta, J.M.; Catchpole, M.; Rogers, P.A.; Hopwood, J.; Randall, S.; Mallinson, H.; Perkins, E.; Jackson, N.; Carlisle, C.; Hewitt, G.; Underhill, G.; Gleave, T.; McLean, L.; Ghosh, A.; Tobin, J.; Harindra, V. // Sexually Transmitted Infections;Feb2003, Vol. 79 Issue 1, p22 

    Studies the prevalence and treatment outcomes among young women screened for Chlamydia trachomatis. Prevalence higher in younger women; Role of project health advisers in managing results and coordinating treatment of positive individuals; Improving awareness and education about sexually...

  • Diagnosis and Management of Gonococcal Infections. MAYOR, MEJEBI T.; ROETT, MICHELLE A.; UDUHIRI, KELECHI A. // American Family Physician;11/15/2012, Vol. 86 Issue 10, p931 

    Neisseria gonorrhoeae causes urogenital, anorectal, conjunctival, and pharyngeal infections. Urogenital tract infections are most common. Men with gonorrhea may present with penile discharge and dysuria, whereas women may present with mucopurulent discharge or pelvic pain; however, women often...

  • Selected Abstracts.  // International Journal of STD & AIDS;Nov2001, Vol. 12 Issue 11, p763 

    The article presents abstracts of researches on sexually transmitted infections. They include "A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy," "A randomized trial of ciprofloxacin versus cefixime for treatment of...

  • UK National Audit of Chlamydial Infection Management in Sexual Health Clinics. Case notes audit: demography, diagnosis and treatment. McClean, Hugo; Carne, Chris; Bunting, Paul; Bhaduri, Sumit; Fernandes, Arnold; Dhar, Jyoti; Estreich, Steve; Daniels, David // International Journal of STD & AIDS;Jul2008, Vol. 19 Issue 7, p469 

    The case notes of cases of genital chlamydial infection were audited against the UK National Guideline. This was the first web-based and the largest national audit to date, with 193 clinics in all UK Regions contributing data. About half of all cases had no symptoms, with about one-third...

  • 2016 European guideline on the management of non-gonococcal urethritis. Horner, Patrick J.; Blee, Karla; Falk, Lars; van der Meijden, Willem; Moi, Harald // International Journal of STD & AIDS;Oct2016, Vol. 27 Issue 11, p928 

    We present the updated International Union against Sexually Transmitted Infections (IUSTI) guideline for the management of non-gonococcal urethritis in men. This guideline recommends confirmation of urethritis in symptomatic men before starting treatment. It does not recommend testing...

  • Testing of Introital Samples for Chlamydia and Trichomonas. Apgar, Barbara // American Family Physician;11/15/1996, Vol. 54 Issue 7, p2291 

    Focuses on Chlamydia Trachomatis and Trichomonas vaginalis, the common sexually transmitted infections associated with adverse pregnancy outcome. Comparison on the usefulness of introital and endocervical specimens in the detection of chlamydial and trichomonal infections; How the infections...

  • Prevalence of Chlamydia trachomatis infection in women having cervical smear tests. Smith, J.R.; Murdoch, J.; Carrington, D.; Frew, C.E.; Dougall, A.J.; MacKinnon, H.; Baillie, D.; Byford, D.M.; Forrest, C.A.; Davis, J.A. // BMJ: British Medical Journal (International Edition);1/12/91, Vol. 302 Issue 6768, p82 

    Examines the prevalence of Chlamydia trachomatis infection in women having cervical smear tests in Glasgow, Scotland. Determination of sexually transmitted infections; Measurement on the rates of chlamydia antibodies; Factors contributing to the prevalence of the infection.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics